JnJ Nipocalimab gets USFDA Fast Track designation for Sjogren's disease Ruchika Sharma19 March 2025 1:30 PM ISTSpring House: Johnson & Johnson has received Fast Track designation (FTD) from the U.S. Food and Drug Administration (FDA) for...
LIC eyes entry into health insurance space by month end Ruchika Sharma19 March 2025 12:30 PM ISTThe Life Insurance Corporation of India (LIC) is expected to make a decision to buy a stake in a health insurance company by the March end, according...
Zydus Lifesciences bags USFDA nod for prostate cancer drug Apalutamide Ruchika Sharma19 March 2025 11:30 AM ISTAhmedabad: Pharma major, Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to...
Strides Pharma Science arm voluntarily dissolves Ruchika Sharma19 March 2025 10:30 AM ISTBengaluru: Strides Pharma Science has announced that Generic Partners UK Ltd, a step-down wholly owned subsidiary of the Company, has been...
Religare Enterprises seeks funding from Burman family Ruchika Sharma18 March 2025 5:13 PM ISTBoard of Religare Enterprises is seeking a governance review of the company and its units. Additionally, the financial services provider has...
Novo Nordisk regains membership in UK pharma body Ruchika Sharma18 March 2025 3:30 PM ISTLondon: Danish pharmaceutical giant Novo Nordisk has regained its membership in the UK's pharmaceutical industry body after serving a two-year...
Shilpa Biologicals, mAbTree Biologics ink pact for cancer drug Ruchika Sharma18 March 2025 12:30 PM ISTKarnataka: Shilpa Biologicals Pvt Ltd., a fully owned subsidiary of Shilpa Medicare Limited has signed an exclusive partnership...
Alembic Global Holding incorporates wholly-owned subsidiary in USA Ruchika Sharma18 March 2025 11:30 AM ISTVadodara: Alembic Global Holding SA, a wholly owned subsidiary of Alembic Pharmaceuticals Limited has incorporated a wholly-owned subsidiary in USA,...
AstraZeneca, Alteogen ink pact for subcutaneous formulations of multiple oncology assets Ruchika Sharma18 March 2025 10:30 AM ISTCambridge: AstraZeneca and Alteogen Inc. have entered into an exclusive license agreement for ALT-B4, a novel hyaluronidase utilising Hybrozyme...
Strides Pharma Science Singapore arm to acquire 100 percent stake in Amexel Ruchika Sharma17 March 2025 5:38 PM ISTBangalore: Strides Pharma Global Pte. Limited (SPG), a step-down wholly-owned Subsidiary of Strides Pharma Science Limited in Singapore, has...
Dr Reddy's Labs recalls epilepsy drug in US over infusion bag mislabeling Ruchika Sharma17 March 2025 5:28 PM ISTHyderabad: Dr Reddy’s Laboratories Ltd., is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 ...
Bayer Finerenone secures USFDA Priority Review designation for heart failure Ruchika Sharma17 March 2025 4:30 PM ISTBerlin: Bayer has announced that the Company has received Priority Review designation from the U.S. Food and Drug Administration (FDA) for finerenone...
